ES2243442T3 - Procedimiento de preparacion de derivados esteroides. - Google Patents

Procedimiento de preparacion de derivados esteroides.

Info

Publication number
ES2243442T3
ES2243442T3 ES01904504T ES01904504T ES2243442T3 ES 2243442 T3 ES2243442 T3 ES 2243442T3 ES 01904504 T ES01904504 T ES 01904504T ES 01904504 T ES01904504 T ES 01904504T ES 2243442 T3 ES2243442 T3 ES 2243442T3
Authority
ES
Spain
Prior art keywords
group
mixture
reaction
represented
steroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01904504T
Other languages
English (en)
Spanish (es)
Inventor
Shingo Yano
Ryutaro Yamagami
Kenji Nozaki
Tetsuji Asao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2243442T3 publication Critical patent/ES2243442T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES01904504T 2000-02-18 2001-02-16 Procedimiento de preparacion de derivados esteroides. Expired - Lifetime ES2243442T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000040927 2000-02-18
JP2000040927 2000-02-18

Publications (1)

Publication Number Publication Date
ES2243442T3 true ES2243442T3 (es) 2005-12-01

Family

ID=18564238

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01904504T Expired - Lifetime ES2243442T3 (es) 2000-02-18 2001-02-16 Procedimiento de preparacion de derivados esteroides.

Country Status (8)

Country Link
US (1) US6717002B2 (de)
EP (1) EP1172371B1 (de)
JP (1) JP4070463B2 (de)
AT (1) ATE297406T1 (de)
DE (1) DE60111304T2 (de)
ES (1) ES2243442T3 (de)
PT (1) PT1172371E (de)
WO (1) WO2001060836A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003004515A1 (en) * 2001-07-06 2003-01-16 Chugai Seiyaku Kabushiki Kaisha Process for production of estradiol derivatives, intermediates used in the process and process for production thereof
WO2004046168A2 (en) * 2002-11-15 2004-06-03 The Henry M. Jackson Foundation Recombinant hiv-1 subclass d envelope glycoproteins
US9907707B2 (en) * 2011-06-03 2018-03-06 The Procter & Gamble Company Sensor systems comprising auxiliary articles
EP4717314A2 (de) 2011-10-14 2026-04-01 Sage Therapeutics, LLC 3,3 disubstituierte 19-nor-pregnanverbindungen, zusammensetzungen und verwendungen davon
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
CN117304245A (zh) 2013-04-17 2023-12-29 萨奇治疗股份有限公司 刺激神经活性的19-去甲类固醇及其使用方法
SMT202100509T1 (it) 2013-04-17 2021-11-12 Sage Therapeutics Inc Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia
CA2918735C (en) 2013-07-19 2023-08-01 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CN105579043B (zh) 2013-08-23 2021-09-14 萨奇治疗股份有限公司 神经活性类固醇、组合物和其用途
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
MY190408A (en) 2014-10-16 2022-04-21 Sage Therapeutics Inc Compositions and methods for treating cns disorders
US20170233433A1 (en) 2014-10-16 2017-08-17 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
WO2016082789A1 (en) 2014-11-27 2016-06-02 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
LT3250210T (lt) 2015-01-26 2021-04-12 Sage Therapeutics, Inc. Kompozicijos ir būdai, skirti gydyti cns sutrikimus
DK3258939T3 (da) 2015-02-20 2022-12-12 Sage Therapeutics Inc Neuroaktive steroider, sammensætninger og anvendelser heraf
WO2018013613A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
CA3030420C (en) 2016-07-11 2025-11-18 Sage Therapeutics, Inc. C7, C12 AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND ASSOCIATED METHODS OF USE
JP7670626B2 (ja) 2019-05-31 2025-04-30 セージ セラピューティクス, インコーポレイテッド 神経刺激性ステロイド及びその組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6784170B2 (en) * 2000-02-11 2004-08-31 Sri International Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one

Also Published As

Publication number Publication date
US6717002B2 (en) 2004-04-06
PT1172371E (pt) 2005-10-31
EP1172371A1 (de) 2002-01-16
US20020143199A1 (en) 2002-10-03
WO2001060836A1 (en) 2001-08-23
JP4070463B2 (ja) 2008-04-02
ATE297406T1 (de) 2005-06-15
EP1172371A4 (de) 2003-04-02
EP1172371B1 (de) 2005-06-08
DE60111304D1 (de) 2005-07-14
DE60111304T2 (de) 2005-11-10

Similar Documents

Publication Publication Date Title
US6717002B2 (en) Method of producing steroid derivatives
US10000524B2 (en) Synthesis of estetrol via estrone derived steroids
ES2590753T3 (es) Proceso para la preparación de esteroides 17-sustituidos
ES2600703T3 (es) Proceso para la producción de intermediarios de estetrol
EP2774933B1 (de) Herstellungsverfahren für ulipristalacetat und zwischenprodukte davon
KR102068381B1 (ko) 담즙산 유도체의 제조 방법
ES2523679T3 (es) Proceso para preparar 7-alfa-[9-(4,4,5,5,5-pentafluorotiopentil)nonil]estra-1,3,5(10)-trien-3,17-beta-diol
JPWO2001060836A1 (ja) ステロイド誘導体の製造法
CA2835981A1 (en) Process for the production of estetrol intermediates
ES2432063T3 (es) Procedimiento para la obtención de 17-espirolactonas en esteroides
WO2013159225A1 (en) Process for preparation of 17-substituted steroids
CN114478672B (zh) 一种he3286的合成方法
ES2342274T3 (es) Reduccion estereoespecifica de sapogen-3-onas.
US20050090675A1 (en) Process for preparing highly pure androstane 17-beta-carboxylic acids and 17-beta-carbothioic acid fluoromethyl esters thereof
CA1306743C (en) DOUBLE ESTER OF 16.beta.-ETHYLESTRAN-17.beta.-OL DERIVATIVES
KR20000064495A (ko) 9,11b-에폭사이드스테로이드의제조방법
ES2425344T3 (es) Un proceso para introducir un enlace doble en la posición 15,16 de un esteroide
US20070117982A1 (en) Method for producing 1,2-unsaturated azasteroids
CN101296936B (zh) 生产甾族化合物的方法
Fernández et al. Studies on the Synthesis of Fused Heterocycles from O-Aminocarbonyl Compounds
JP4490560B2 (ja) ステロイド誘導体の製造法
CN118878609A (zh) 一种地屈孕酮及其中间体的绿色合成方法
JPH0367067B2 (de)
CS270783B1 (cs) 2 <6,3 Z-Isoalkylidendioxy-17Q-(3 -methyl)- -butyryloxy-7-oxa-B-homo-5 Z- -androstan-6-on
HK1214239B (en) Process for preparing bile acid derivatives